vs
Side-by-side financial comparison of Northfield Bancorp, Inc. (NFBK) and PUMA BIOTECHNOLOGY, INC. (PBYI). Click either name above to swap in a different company.
PUMA BIOTECHNOLOGY, INC. is the larger business by last-quarter revenue ($75.5M vs $41.3M, roughly 1.8× Northfield Bancorp, Inc.). On growth, PUMA BIOTECHNOLOGY, INC. posted the faster year-over-year revenue change (27.7% vs 12.7%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $14.4M). Over the past eight quarters, PUMA BIOTECHNOLOGY, INC.'s revenue compounded faster (31.3% CAGR vs 15.0%).
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
Puma Biotechnology is a publicly traded biopharmaceutical company headquartered in Los Angeles, CA.
NFBK vs PBYI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $41.3M | $75.5M |
| Net Profit | $-27.4M | — |
| Gross Margin | — | 69.3% |
| Operating Margin | -1263.3% | 22.7% |
| Net Margin | -1545.5% | — |
| Revenue YoY | 12.7% | 27.7% |
| Net Profit YoY | -343.6% | — |
| EPS (diluted) | $-0.68 | $0.26 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $41.3M | $75.5M | ||
| Q3 25 | $39.2M | $54.5M | ||
| Q2 25 | $38.9M | $52.4M | ||
| Q1 25 | $34.8M | $46.0M | ||
| Q4 24 | $36.7M | $59.1M | ||
| Q3 24 | $31.8M | $80.5M | ||
| Q2 24 | $31.5M | $47.1M | ||
| Q1 24 | $31.3M | $43.8M |
| Q4 25 | $-27.4M | — | ||
| Q3 25 | $10.8M | $8.8M | ||
| Q2 25 | $9.6M | $5.9M | ||
| Q1 25 | $7.9M | $3.0M | ||
| Q4 24 | $11.3M | — | ||
| Q3 24 | $6.5M | $20.3M | ||
| Q2 24 | $6.0M | $-4.5M | ||
| Q1 24 | $6.2M | $-4.8M |
| Q4 25 | — | 69.3% | ||
| Q3 25 | — | 77.7% | ||
| Q2 25 | — | 76.5% | ||
| Q1 25 | — | 77.1% | ||
| Q4 24 | — | 76.4% | ||
| Q3 24 | — | 63.9% | ||
| Q2 24 | — | 77.4% | ||
| Q1 24 | — | 75.5% |
| Q4 25 | -1263.3% | 22.7% | ||
| Q3 25 | 37.7% | 17.6% | ||
| Q2 25 | 35.6% | 12.7% | ||
| Q1 25 | 31.0% | 8.7% | ||
| Q4 24 | 38.0% | 22.6% | ||
| Q3 24 | 27.9% | 27.4% | ||
| Q2 24 | 29.1% | -4.6% | ||
| Q1 24 | 27.2% | -5.3% |
| Q4 25 | -1545.5% | — | ||
| Q3 25 | 27.4% | 16.2% | ||
| Q2 25 | 24.6% | 11.2% | ||
| Q1 25 | 22.6% | 6.5% | ||
| Q4 24 | 30.7% | — | ||
| Q3 24 | 20.5% | 25.2% | ||
| Q2 24 | 18.9% | -9.6% | ||
| Q1 24 | 19.9% | -11.0% |
| Q4 25 | $-0.68 | $0.26 | ||
| Q3 25 | $0.27 | $0.17 | ||
| Q2 25 | $0.24 | $0.12 | ||
| Q1 25 | $0.19 | $0.06 | ||
| Q4 24 | $0.27 | $0.40 | ||
| Q3 24 | $0.16 | $0.41 | ||
| Q2 24 | $0.14 | $-0.09 | ||
| Q1 24 | $0.15 | $-0.10 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.0M | $97.5M |
| Total DebtLower is stronger | — | $22.7M |
| Stockholders' EquityBook value | $690.1M | $130.3M |
| Total Assets | $5.8B | $216.3M |
| Debt / EquityLower = less leverage | — | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.0M | $97.5M | ||
| Q3 25 | $131.7M | $94.4M | ||
| Q2 25 | $97.6M | $96.0M | ||
| Q1 25 | $101.7M | $93.2M | ||
| Q4 24 | $167.7M | $101.0M | ||
| Q3 24 | $232.9M | $96.7M | ||
| Q2 24 | $153.5M | $96.8M | ||
| Q1 24 | $238.8M | $107.2M |
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | $666.4M | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
| Q4 25 | $690.1M | $130.3M | ||
| Q3 25 | $719.6M | $115.3M | ||
| Q2 25 | $710.3M | $104.7M | ||
| Q1 25 | $711.1M | $97.1M | ||
| Q4 24 | $704.7M | $92.1M | ||
| Q3 24 | $699.6M | $71.1M | ||
| Q2 24 | $693.0M | $48.5M | ||
| Q1 24 | $698.4M | $51.0M |
| Q4 25 | $5.8B | $216.3M | ||
| Q3 25 | $5.7B | $202.9M | ||
| Q2 25 | $5.7B | $194.9M | ||
| Q1 25 | $5.7B | $196.2M | ||
| Q4 24 | $5.7B | $213.3M | ||
| Q3 24 | $5.7B | $220.7M | ||
| Q2 24 | $5.7B | $205.0M | ||
| Q1 24 | $5.9B | $214.1M |
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | 0.95× | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $53.7M | $14.4M |
| Free Cash FlowOCF − Capex | $52.5M | $14.4M |
| FCF MarginFCF / Revenue | 127.1% | 19.1% |
| Capex IntensityCapex / Revenue | 2.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $89.2M | $41.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $53.7M | $14.4M | ||
| Q3 25 | $13.9M | $9.7M | ||
| Q2 25 | $14.1M | $14.1M | ||
| Q1 25 | $9.4M | $3.6M | ||
| Q4 24 | $31.1M | $15.6M | ||
| Q3 24 | $14.0M | $11.0M | ||
| Q2 24 | $6.9M | $1.0M | ||
| Q1 24 | $4.2M | $11.2M |
| Q4 25 | $52.5M | $14.4M | ||
| Q3 25 | $13.6M | $9.7M | ||
| Q2 25 | $13.9M | $14.1M | ||
| Q1 25 | $9.2M | $3.6M | ||
| Q4 24 | $30.0M | $15.6M | ||
| Q3 24 | $13.7M | $11.0M | ||
| Q2 24 | $6.7M | $1.0M | ||
| Q1 24 | $3.8M | — |
| Q4 25 | 127.1% | 19.1% | ||
| Q3 25 | 34.6% | 17.7% | ||
| Q2 25 | 35.7% | 26.8% | ||
| Q1 25 | 26.3% | 7.7% | ||
| Q4 24 | 81.6% | 26.4% | ||
| Q3 24 | 43.2% | 13.7% | ||
| Q2 24 | 21.1% | 2.1% | ||
| Q1 24 | 12.1% | — |
| Q4 25 | 2.8% | 0.0% | ||
| Q3 25 | 0.8% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 0.7% | 0.1% | ||
| Q4 24 | 3.1% | 0.0% | ||
| Q3 24 | 0.7% | 0.0% | ||
| Q2 24 | 0.8% | 0.0% | ||
| Q1 24 | 1.4% | 0.0% |
| Q4 25 | — | — | ||
| Q3 25 | 1.29× | 1.10× | ||
| Q2 25 | 1.48× | 2.41× | ||
| Q1 25 | 1.20× | 1.21× | ||
| Q4 24 | 2.76× | — | ||
| Q3 24 | 2.14× | 0.54× | ||
| Q2 24 | 1.16× | — | ||
| Q1 24 | 0.68× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
